Log in to your Inderes Free account to see all free content on this page.
Virogates
10.90 DKK
-0.91 %
Less than 1K followers
VIRO
First North Denmark
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-0.91 %
-4.39 %
-13.83 %
-18.96 %
-28.29 %
+32.28 %
-35.45 %
-93.10 %
-83.47 %
Virogates is active in medical technology. The company is active in research and development of biomarkers and diagnostic instruments for the healthcare industry. The products are sold under various brands and are used in the identification, analysis and further treatment of diseases, primarily cardiovascular diseases, cancer and neurological diseases. The company was established in 2001 and is headquartered in Birkerød.
Read moreMarket cap
101.2M DKK
Turnover
14.73K DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.8.
2026
Interim report Q2'26
5.11.
2026
Interim report Q3'26
All
Press releases
3rd party
ShowingAll content types
Resolutions from the Annual General Meeting of ViroGates A/S
ViroGates submits its De Novo application to the U.S. FDA for suPARnostic® TurbiLatex
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio